The 3rd Central Labs & Diagnostics Partnerships Forum is a gathering place to learn about and discuss pressing issues involving sample management, transport logistics, innovative technologies, imaging diagnostics and more! To learn more about sponsoring or exhibiting at this event, reach out to Andrew Sinetar, Managing Director of Strategic Business Development, at 212-400-6237 or email@example.com.
Cancer Genetics, Inc. is a leader in enabling precision medicine from bench-to-bedside. In addition to its clinical diagnostics business, Cancer Genetics actively supports biopharma companies with genomic-based, comprehensive oncology biomarker testing and companion diagnostic strategies through its state-of-the-art CLIA-certified and CAP-accredited reference labs in New Jersey and California.
Covance Inc., the drug development business of Laboratory Corporation of America Holdings (LabCorp) headquartered in Princeton, New Jersey, USA, is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real®. Information on Covance’s solutions can be obtained through its website at www.covance.com.
PPD® is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and life cycle management services. PPD® Laboratories combines world-class scientific expertise with state-of-the art technologies supported by a commitment to exceptional quality. Our clients benefit from comprehensive lab services spanning bioanalytical, vaccine sciences, GMP, central lab testing and biomarkers. Our laboratory services accelerate pharmaceutical development for small molecules and biologics, allowing clients to make faster decisions about their compounds.